Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01686828 · ClinicalTrials.gov registry record · Phase 1
T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
NCT01686828 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 53 participants.
The verdict
NCT01686828, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand the effects of testosterone and estrogen on the body's response to the hormone insulin.
Interventions
- DRUG Letrozole
- DRUG Acyline
- DRUG Testosterone 1.62% gel
- DRUG Placebo gel (for Testosterone 1.62% gel)
- DRUG Placebo pill (for Letrozole)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01686828
The ClinicalTrials.gov registry entry for NCT01686828 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Letrozole is the first listed.
NCT01686828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01686828 about?
NCT01686828 is a clinical study titled "T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin". The purpose of this research study is to understand the effects of testosterone and estrogen on the body's response to the hormone insulin.
What is the current status of trial NCT01686828?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2013-06. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01686828?
The interventions under investigation include: Letrozole (DRUG), Acyline (DRUG), Testosterone 1.62% gel (DRUG), Placebo gel (for Testosterone 1.62% gel) (DRUG), Placebo pill (for Letrozole) (DRUG).
Who is sponsoring clinical trial NCT01686828?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.